Adicet Bio, Inc.
ACET · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $55,562 | $68,759 | $84,528 |
| - Cash | $29,099 | $34,720 | $28,133 | $56,495 |
| + Debt | $12,271 | $15,358 | $16,245 | $17,234 |
| Enterprise Value | – | $36,200 | $56,871 | $45,267 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$25,271 | -$29,562 | -$26,534 | -$27,103 |
| % Margin | – | – | – | – |
| Net Income | -$26,856 | -$31,217 | -$28,214 | -$28,727 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.29 | -0.34 | -0.31 | -0.32 |
| % Growth | 14.7% | -9.7% | 3.1% | – |
| Operating Cash Flow | -$22,307 | -$26,633 | -$25,397 | -$24,101 |
| Capital Expenditures | -$209 | -$47 | -$1,492 | -$176 |
| Free Cash Flow | -$22,516 | -$26,680 | -$26,889 | -$24,277 |